Immune therapy could offer hope for halting Alzheimer’s progression

An immune therapy in the testing phase could be the first long-term treatment to halt the progression of Alzheimer’s, researchers said at AAIC. IVIG/Gammagard showed promise after being given intravenously for three years to a small study group. While the participants did not show improvement in most Alzheimer’s symptoms they already had, they showed no further decline on measures of cognition, memory, daily functioning or mood.
Read the article >>

http://www.usatoday.com/news/health/story/2012-07-16/alzheimers-treatment-gammagard/56270084/1